InsiderTrades

Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC

Accepted 2022-01-07 00:00:00 ET · period of report 2021-12-01 · accession 0001209191-22-002447 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
M 2022-01-07 2021-12-01+ CPIX Cearnal Martin E SVP, Chief Commercial Off, Dir P - Purchase $4.53 +2,114 178.2K +1% +$9,571

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-01 P A 90 $4.14 176,449 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
2 Common Common Stock 2021-12-20 P A 314 $4.33 178,473 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
3 Common Common Stock 2021-12-03 P A 90 $4.47 176,629 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
4 Common Common Stock 2021-12-06 P A 90 $4.46 176,719 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
5 Common Common Stock 2021-12-07 P A 90 $5.61 176,809 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
6 Common Common Stock 2021-12-08 P A 90 $6.15 176,899 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
7 Common Common Stock 2021-12-09 P A 90 $5.81 176,989 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
8 Common Common Stock 2021-12-10 P A 90 $4.82 177,079 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
9 Common Common Stock 2021-12-13 P A 200 $4.36 177,279 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
10 Common Common Stock 2021-12-14 P A 200 $4.28 177,479 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
11 Common Common Stock 2021-12-02 P A 90 $3.84 176,539 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
12 Common Common Stock 2021-12-15 P A 200 $4.29 177,679 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
13 Common Common Stock 2021-12-16 P A 240 $4.53 177,919 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.
14 Common Common Stock 2021-12-17 P A 240 $4.17 178,159 D — — (F1) The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.